Clinical Trial Update: A Study to Evaluate the Value of Circulating Tumour DNA in Follow-up of Patients With an Advanced Gastroenteropancreatic or Lung Neuroendocrine Tumour Under Everolimus +- SSA Treatment [NA]

View source ↗

Summary

A completed study evaluating whether circulating tumor DNA can be used in follow-up of patients with advanced gastroenteropancreatic or lung neuroendocrine tumo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumor
• Lung Neuroendocrine Tumor

Drugs mentioned

• Afinitor (everolimus)

Snippet

Sponsor: Universiteit Antwerpen | Conditions: Neuroendocrine Tumors | NA | Status: COMPLETED